Bausch Health (NYSE: BHC) director receives $250,000 RSU equity grant

Rhea-AI Filing Summary

POWER ROBERT N reported acquisition or exercise transactions in this Form 4 filing.

Bausch Health Companies Inc. reported that director Robert N. Power received an equity grant in the form of restricted share units. He was awarded 45,871 RSUs with a grant date value of $250,000, which will vest immediately before the company’s next Annual Meeting of Shareholders and be settled in common shares. Following this grant, he directly holds 300,594 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider POWER ROBERT N

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	45,871	$0.00	--

Holdings After Transaction: Common Shares, No Par Value — 300,594 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 45,871 units Grant date value: $250,000 Transaction price per share: $0.00 +1 more

4 metrics

RSUs granted 45,871 units Restricted share units awarded to non-employee director

Grant date value $250,000 Value of RSU award for non-employee director

Transaction price per share $0.00 Compensation grant, not a market purchase

Shares held after transaction 300,594 shares Director’s direct ownership following RSU grant

Key Terms

restricted share units ("RSUs"), grant date value, vest, settled in common shares

4 terms

restricted share units ("RSUs") financial

"Represents the award of restricted share units ("RSUs") granted to non-employee directors"

grant date value financial

"The RSUs have a grant date value of $250,000"

vest financial

"The RSUs have a grant date value of $250,000, vest on the date immediately preceding"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settled in common shares financial

"and are settled in common shares, no par value, of the Issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 05/26/2026 - 07:00 PM Accepted by SEC EDGAR 05/26/2026 - 07:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Bausch Health (BHC) director Robert N. Power report?

Robert N. Power reported receiving a grant of 45,871 restricted share units. These RSUs were awarded as compensation to a non-employee director and will be settled in Bausch Health common shares once they vest before the next Annual Meeting.

What is the value of the RSU award reported in Bausch Health (BHC)’s Form 4?

The RSU award has a grant date value of $250,000. This value reflects the compensation granted to the non-employee director in equity form, which vests over time and is ultimately settled in common shares of Bausch Health.

When do Robert N. Power’s Bausch Health (BHC) RSUs vest?

The RSUs vest on the date immediately preceding Bausch Health’s next Annual Meeting of Shareholders. At that time, the restricted share units convert into common shares, aligning the director’s compensation with shareholder interests over the service period.

How many Bausch Health (BHC) shares does Robert N. Power hold after this Form 4 transaction?

After the reported RSU grant, Robert N. Power directly holds 300,594 common shares. This figure includes the impact of the newly granted restricted share units, which will be settled in common shares once they vest according to the award terms.

How were the Bausch Health (BHC) RSUs for Robert N. Power priced in the Form 4?

The transaction price per share is shown as $0.00 because this is a compensation-related grant, not a market purchase. The economic value is represented instead by the RSUs’ grant date value of $250,000 disclosed in the footnote.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POWER ROBERT N

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/22/2026		A		45,871(1)	A	$0	300,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)